LENZ Therapeutics

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-10
-18
-5
EBITDA
-15,200
-12,935
-14,334
-16,083
EBIT
-15,225
-12,945
-14,352
-16,088
Net Income
-12,652
-10,215
-10,254
-16,648
Net Change In Cash
0
0
0
0
Free Cash Flow
-9,227
-10,767
-15,928
-23,937
Cash
20,158
41,046
84,149
200,357
Basic Shares
27,172
27,172
25,608
4,717

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$15,000
$0
Gross Profit
-2,407
6,654
-734
EBITDA
-122,244
-97,293
-70,026
EBIT
-124,651
-105,639
-70,760
Net Income
-49,769
-124,651
-101,052
-70,760
Net Change In Cash
0
0
15,000
0
Free Cash Flow
-59,859
-100,863
-94,574
-58,592
Cash
20,158
35,140
47,730
376,976
Basic Shares
27,518
8,145
7,839
8,287

Earnings Calls

Quarter EPS
2024-12-31
-$0.46
2024-09-30
-$0.38
2024-06-30
-$0.40
2024-03-31
-$3.53